The Federal Trade Commission is planning to announce preliminary results from its ongoing in-depth investigation of potentially anti-competitive behavior in the pharmacy benefit manager industry much sooner than previous efforts, according to commission Chair Lina Khan.
“It’s very much traditional for these ‘6b’ studies at the agency to take five years, six years” but “we’ve been...







